吉西他滨临床使用合理性的调查分析(2)
[3]赵可新,胡建平,单靖珊,等.盐酸吉西他滨临床应用进展[J].中国医药导报,2006,3(36):13-15.
[4]刘秀峰,秦叔逵.如何优化吉西他滨在晚期胆系肿瘤中的应用[J].临床肿瘤学杂志,2013,18(5):453-457.
[5]Valle JW,Wasan HS,Palmer DD,et al.Gemcitabine with or without cisplatin in patients with advanced or metastatic biliary tract cancer: results of a multicenter,randomized phase Ⅲ trial (the UK ABC-02 trial) [J]. J Clin Oncol,2009,27( 15 Suppl) : a4503.
[6]Valle J,Wasan H,Palmer DH,et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J].N Engl J Med,2010,362( 14) : 1273- 1281.
[7]KimbyE, Brandt L, Nygren P, et al A systematic overview of chemotherapy effects in aggressiven on-Hodgkins' lymphoma[J].Acta Oncol,2001, 40(2-3): 198-212.
[8]OkiY, McLaughlin P, ProB, et al PhaseII study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma[J]. Cancer, 2005, 104(4): 781-787.
[9]杜书静,孙勇.吉西他滨联合长春瑞滨治疗难治性非霍奇金淋巴瘤的临床观察[J].中国医药指南,2012,10(10):13-14.
[10]金永东,卢进,梅开.吉西他滨联合奈达铂治疗复发或难治性侵袭性非霍奇金淋巴瘤[J].中国肿瘤临床与康复,2013,20(4):332-334.
[11]汪荃,王淑梅,逄丽红,等.吉西他滨治疗复发、难治性非霍奇金淋巴瘤临床观察[J].中华肿瘤防治杂志,2006,13(20):2014.
[12]张伶俐,李幼平,曾力楠,等.15国超说明书用药政策的循证评价[J].中国询证医学杂志,2012,12(4):426-435.编辑/申磊, 百拇医药(林美丽 寿军 鲁兖 等)
[4]刘秀峰,秦叔逵.如何优化吉西他滨在晚期胆系肿瘤中的应用[J].临床肿瘤学杂志,2013,18(5):453-457.
[5]Valle JW,Wasan HS,Palmer DD,et al.Gemcitabine with or without cisplatin in patients with advanced or metastatic biliary tract cancer: results of a multicenter,randomized phase Ⅲ trial (the UK ABC-02 trial) [J]. J Clin Oncol,2009,27( 15 Suppl) : a4503.
[6]Valle J,Wasan H,Palmer DH,et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J].N Engl J Med,2010,362( 14) : 1273- 1281.
[7]KimbyE, Brandt L, Nygren P, et al A systematic overview of chemotherapy effects in aggressiven on-Hodgkins' lymphoma[J].Acta Oncol,2001, 40(2-3): 198-212.
[8]OkiY, McLaughlin P, ProB, et al PhaseII study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma[J]. Cancer, 2005, 104(4): 781-787.
[9]杜书静,孙勇.吉西他滨联合长春瑞滨治疗难治性非霍奇金淋巴瘤的临床观察[J].中国医药指南,2012,10(10):13-14.
[10]金永东,卢进,梅开.吉西他滨联合奈达铂治疗复发或难治性侵袭性非霍奇金淋巴瘤[J].中国肿瘤临床与康复,2013,20(4):332-334.
[11]汪荃,王淑梅,逄丽红,等.吉西他滨治疗复发、难治性非霍奇金淋巴瘤临床观察[J].中华肿瘤防治杂志,2006,13(20):2014.
[12]张伶俐,李幼平,曾力楠,等.15国超说明书用药政策的循证评价[J].中国询证医学杂志,2012,12(4):426-435.编辑/申磊, 百拇医药(林美丽 寿军 鲁兖 等)